Reason for request
Inclusion
Clinical Benefit
| Moderate |
Moderate AB pending re-assessment of oral antihistamines. |
Clinical Added Value
| no clinical added value |
No improvement in actual benefit (IAB V) compared with other oral H1 antihistamines available in oral form. |
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
MR8R0uWag6A9p4tq
Listen
